- Reuters - UK Focus•3 years ago
Generic drugmaker Actavis Plc has won U.S. approval to buy specialty pharmaceuticals company Forest Laboratories on condition it sell or relinquish the rights to four generic medicines, the Federal Trade ...
- CNBC•3 years ago
U.S. stocks opened higher on Monday, bouncing back after the prior session's sharp drop, as investors embraced increased deal activity.
- Investor's Business Daily•3 years ago
Stock futures put in a strong advance ahead of Monday's open, as investors eyed a rebound after Friday's sharp sell-off. Dow futures were steady, 86.5 points above fair market value. Nasdaq 100 futures ...
Requested symbol wasn't found
NasdaqGS . Currency in USD
Add to watchlist
|Bid||N/A x N/A|
|Ask||N/A x N/A|
|Day's range||N/A - N/A|
|52-week range||undefined - undefined|
Trade prices are not sourced from all markets
|PE ratio (TTM)||N/A|
|Dividend & yield||N/A (N/A)|
|1y target est||N/A|